Title of article :
Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
Author/Authors :
Feizi, Jalil Department of Infectious Diseases - School of Medicine - Ilam University of Medical Sciences - Ilam - Iran , Ghaysouri, Abbas Department of Pulmonary - Shahid Mostafa Khomeini Hospital - Ilam University of Medical Sciences - Ilam - Iran , Bonyadi, Mahtab Clinical Research Development Unit - Shahid Mostafa Khomeini Hospital - Ilam University of Medical Sciences - Ilam - Iran , Shafiei, Elham Clinical Research Development Unit - Shahid Mostafa Khomeini Hospital - Ilam University of Medical Sciences - Ilam - Iran
Abstract :
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding
Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis.
Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.
Keywords:
Keywords :
Vascular thrombosis , Rivaroxaban , Anticoagulant
Journal title :
International Journal of Medical Toxicology and Forensic Medicine
